James P. Kelly
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-10-12–present
-
Start not stated–2020-03-15
-
Start not stated–2021-08-13
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Vanda Pharmaceuticals Inc. (VNDA) | Former Executive Vice President, Chief Financial Officer and Treasurer | $124,057 | $140,274 |
| 2020 | Supernus Pharmaceuticals, Inc. (SUPN) | Executive Vice President, Chief Financial Officer | $102,910 | $1,801,636 |
| 2019 | Vanda Pharmaceuticals Inc. (VNDA) | Former Executive Vice President, Chief Financial Officer and Treasurer | $493,370 | $2,248,410 |
| 2018 | Vanda Pharmaceuticals Inc. (VNDA) | Former Executive Vice President, Chief Financial Officer and Treasurer | $479,000 | $2,401,385 |
| 2017 | Vanda Pharmaceuticals Inc. (VNDA) | Former Executive Vice President, Chief Financial Officer and Treasurer | $465,000 | $2,276,307 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.